The University of Southampton
University of Southampton Institutional Repository

Early computed tomography coronary angiography and preventative treatment in patients with suspected acute coronary syndrome: a secondary analysis of the RAPID-CTCA trial

Early computed tomography coronary angiography and preventative treatment in patients with suspected acute coronary syndrome: a secondary analysis of the RAPID-CTCA trial
Early computed tomography coronary angiography and preventative treatment in patients with suspected acute coronary syndrome: a secondary analysis of the RAPID-CTCA trial
Background: computed tomography coronary angiography (CTCA) offers detailed assessment of the presence of coronary atherosclerosis and helps guide patient management. We investigated influences of early CTCA on the subsequent use of preventative treatment in patients with suspected acute coronary syndrome.

Methods: in this secondary analysis of a multicenter randomized controlled trial of early CTCA in intermediate-risk patients with suspected acute coronary syndrome, prescription of aspirin, P2Y12 receptor antagonist, statin, renin–angiotensin system blocker, and beta-blocker therapies from randomization to discharge were compared within then between those randomized to early CTCA or to standard of care only. Effects of CTCA findings on adjustment of these therapies were further examined.

Results: in 1,743 patients (874 randomized to early CTCA and 869 to standard of care only), prescription of P2Y12 receptor antagonist, dual antiplatelet, and statin therapies increased more in the early CTCA group (between-group difference: 4.6% [95% confidence interval, 0.3-8.9], 4.5% [95% confidence interval, 0.2-8.7], and 4.3% [95% confidence interval, 0.2-8.5], respectively), whereas prescription of other preventative therapies increased by similar extent in both study groups. Among patients randomized to early CTCA, there were additional increments of preventative treatment in those with obstructive coronary artery disease and higher rates of reductions in antiplatelet and beta-blocker therapies in those with normal coronary arteries.

Conclusions: prescription patterns of preventative treatment varied during index hospitalization in patients with suspected acute coronary syndrome. Early CTCA facilitated targeted individualization of these therapies based on the extent of coronary artery disease.
0002-8703
138-148
Wang, Kang-Ling
18a1213e-e27e-4253-a3ee-39a94f04a5ea
Meah, Mohammed N.
dad089a9-c89d-4458-9b4c-6d800faf1840
Bularga, Anda
a37c4d61-0f64-4c7b-bb67-5c1ddd46fd8f
Oatey, Katherine
21f201d1-2be1-45d4-ac53-e773e26f399e
O'Brien, Rachel
d3be66af-28b9-4f30-a732-9b7e321e0ba6
Smith, Jason E.
8199452a-0e4c-4dbd-b598-23b1505919e6
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Kardos, Attila
a23428f1-301f-4adb-b980-65f31dd9fef2
Keating, Liza
a1c5f887-6f5d-4caa-b6d1-e1ebc5d3f507
Felmeden, Dirk
116b66e8-a109-4172-ac5a-e72cc69fe2e7
Storey, Robert F.
892bb08c-5356-4fd8-a77c-2accce8e10f8
Goodacre, Steve
a4c9c41f-44a4-4de9-ac6d-7c4c0daa5b05
Roobottom, Carl
80aa86b6-c2d2-4c2a-adf6-22701dd67f19
Newby, David E.
8684bf8c-1189-4f56-a666-c122bd9073c5
Gray, Alasdair J.
7f312647-2e4d-4fe8-847b-ad2cf464d75d
RAPID-CTCA Investigators
Wang, Kang-Ling
18a1213e-e27e-4253-a3ee-39a94f04a5ea
Meah, Mohammed N.
dad089a9-c89d-4458-9b4c-6d800faf1840
Bularga, Anda
a37c4d61-0f64-4c7b-bb67-5c1ddd46fd8f
Oatey, Katherine
21f201d1-2be1-45d4-ac53-e773e26f399e
O'Brien, Rachel
d3be66af-28b9-4f30-a732-9b7e321e0ba6
Smith, Jason E.
8199452a-0e4c-4dbd-b598-23b1505919e6
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Kardos, Attila
a23428f1-301f-4adb-b980-65f31dd9fef2
Keating, Liza
a1c5f887-6f5d-4caa-b6d1-e1ebc5d3f507
Felmeden, Dirk
116b66e8-a109-4172-ac5a-e72cc69fe2e7
Storey, Robert F.
892bb08c-5356-4fd8-a77c-2accce8e10f8
Goodacre, Steve
a4c9c41f-44a4-4de9-ac6d-7c4c0daa5b05
Roobottom, Carl
80aa86b6-c2d2-4c2a-adf6-22701dd67f19
Newby, David E.
8684bf8c-1189-4f56-a666-c122bd9073c5
Gray, Alasdair J.
7f312647-2e4d-4fe8-847b-ad2cf464d75d

RAPID-CTCA Investigators (2023) Early computed tomography coronary angiography and preventative treatment in patients with suspected acute coronary syndrome: a secondary analysis of the RAPID-CTCA trial. American Heart Journal, 266, 138-148. (doi:10.1016/j.ahj.2023.09.003).

Record type: Article

Abstract

Background: computed tomography coronary angiography (CTCA) offers detailed assessment of the presence of coronary atherosclerosis and helps guide patient management. We investigated influences of early CTCA on the subsequent use of preventative treatment in patients with suspected acute coronary syndrome.

Methods: in this secondary analysis of a multicenter randomized controlled trial of early CTCA in intermediate-risk patients with suspected acute coronary syndrome, prescription of aspirin, P2Y12 receptor antagonist, statin, renin–angiotensin system blocker, and beta-blocker therapies from randomization to discharge were compared within then between those randomized to early CTCA or to standard of care only. Effects of CTCA findings on adjustment of these therapies were further examined.

Results: in 1,743 patients (874 randomized to early CTCA and 869 to standard of care only), prescription of P2Y12 receptor antagonist, dual antiplatelet, and statin therapies increased more in the early CTCA group (between-group difference: 4.6% [95% confidence interval, 0.3-8.9], 4.5% [95% confidence interval, 0.2-8.7], and 4.3% [95% confidence interval, 0.2-8.5], respectively), whereas prescription of other preventative therapies increased by similar extent in both study groups. Among patients randomized to early CTCA, there were additional increments of preventative treatment in those with obstructive coronary artery disease and higher rates of reductions in antiplatelet and beta-blocker therapies in those with normal coronary arteries.

Conclusions: prescription patterns of preventative treatment varied during index hospitalization in patients with suspected acute coronary syndrome. Early CTCA facilitated targeted individualization of these therapies based on the extent of coronary artery disease.

Text
1-s2.0-S0002870323002752-main - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 6 September 2023
e-pub ahead of print date: 12 September 2023
Published date: 16 October 2023

Identifiers

Local EPrints ID: 492008
URI: http://eprints.soton.ac.uk/id/eprint/492008
ISSN: 0002-8703
PURE UUID: 51e46f4c-309a-4928-b499-56bb904534f7
ORCID for Nick Curzen: ORCID iD orcid.org/0000-0001-9651-7829

Catalogue record

Date deposited: 11 Jul 2024 16:41
Last modified: 12 Jul 2024 01:43

Export record

Altmetrics

Contributors

Author: Kang-Ling Wang
Author: Mohammed N. Meah
Author: Anda Bularga
Author: Katherine Oatey
Author: Rachel O'Brien
Author: Jason E. Smith
Author: Nick Curzen ORCID iD
Author: Attila Kardos
Author: Liza Keating
Author: Dirk Felmeden
Author: Robert F. Storey
Author: Steve Goodacre
Author: Carl Roobottom
Author: David E. Newby
Author: Alasdair J. Gray
Corporate Author: RAPID-CTCA Investigators

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×